Literature DB >> 25956158

Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies.

Giorgia Zadra1, Julie L Batista2, Massimo Loda3.   

Abstract

The precise role of 5'AMP-activated kinase (AMPK) in cancer and its potential as a therapeutic target is controversial. Although it is well established that activation of this energy sensor inhibits the main anabolic processes that sustain cancer cell proliferation and growth, AMPK activation can confer on cancer cells the plasticity to survive under metabolic stress such as hypoxia and glucose deprivation, which are commonly observed in fast growing tumors. Thus, AMPK is referred to as both a "conditional" tumor suppressor and "contextual" oncogene. To add a further layer of complexity, AMPK activation in human cancer tissues and its correlation with tumor aggressiveness and progression appears to vary in different contexts. The current review discusses the different faces of this metabolic regulator, the therapeutic implications of its modulation, and provides an overview of the most relevant data available on AMPK activation and AMPK-activating drugs in human studies. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25956158      PMCID: PMC4504770          DOI: 10.1158/1541-7786.MCR-15-0068

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  144 in total

1.  Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.

Authors:  Soley Bayraktar; Leonel F Hernadez-Aya; Xiudong Lei; Funda Meric-Bernstam; Jennifer K Litton; Limin Hsu; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Journal:  Cancer       Date:  2011-07-28       Impact factor: 6.860

2.  Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer.

Authors:  Fung Yu Huang; Pui Man Chiu; Kar Fai Tam; Yvonne K Y Kwok; Elizabeth T Lau; Mary H Y Tang; Tong Yow Ng; Vincent W S Liu; Annie N Y Cheung; Hextan Y S Ngan
Journal:  Gynecol Oncol       Date:  2006-04-03       Impact factor: 5.482

3.  5'-AMP-activated protein kinase (AMPK) supports the growth of aggressive experimental human breast cancer tumors.

Authors:  Keith R Laderoute; Joy M Calaoagan; Wan-Ru Chao; Dominc Dinh; Nicholas Denko; Sarah Duellman; Jessica Kalra; Xiaohe Liu; Ioanna Papandreou; Lidia Sambucetti; Laszlo G Boros
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

4.  A pilot characterization of human lung NSCLC by protein pathway activation mapping.

Authors:  Angela Zupa; Giuseppina Improta; Alessandra Silvestri; Elisa Pin; Jianghong Deng; Michele Aieta; Pellegrino Musto; Donato Nitti; Enzo Mammano; Lance Liotta; Claudio Belluco; Julia Wulfkuhle; Emanuel Petricoin
Journal:  J Thorac Oncol       Date:  2012-12       Impact factor: 15.609

Review 5.  Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase.

Authors:  D G Hardie; D A Pan
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

6.  Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer.

Authors:  Ido Laskov; Laura Drudi; Marie-Claude Beauchamp; Amber Yasmeen; Alex Ferenczy; Michael Pollak; Walter H Gotlieb
Journal:  Gynecol Oncol       Date:  2014-06-24       Impact factor: 5.482

7.  Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.

Authors:  Longyi Zheng; Wen Yang; Fuquan Wu; Chao Wang; Lexing Yu; Liang Tang; Bijun Qiu; Yuqiong Li; Linna Guo; Mengchao Wu; Gensheng Feng; Dajin Zou; Hongyang Wang
Journal:  Clin Cancer Res       Date:  2013-08-13       Impact factor: 12.531

8.  Structure of mammalian AMPK and its regulation by ADP.

Authors:  Bing Xiao; Matthew J Sanders; Elizabeth Underwood; Richard Heath; Faith V Mayer; David Carmena; Chun Jing; Philip A Walker; John F Eccleston; Lesley F Haire; Peter Saiu; Steven A Howell; Rein Aasland; Stephen R Martin; David Carling; Steven J Gamblin
Journal:  Nature       Date:  2011-03-13       Impact factor: 49.962

9.  Histological evaluation of AMPK signalling in primary breast cancer.

Authors:  Sirwan M Hadad; Lee Baker; Philip R Quinlan; Katherine E Robertson; Susan E Bray; George Thomson; David Kellock; Lee B Jordan; Colin A Purdie; David G Hardie; Stewart Fleming; Alastair M Thompson
Journal:  BMC Cancer       Date:  2009-09-01       Impact factor: 4.430

10.  Identification of a novel AMPK-PEA15 axis in the anoikis-resistant growth of mammary cells.

Authors:  Sravanth K Hindupur; Sai A Balaji; Meera Saxena; Shubham Pandey; Gopalkrishnashetty Sreenivasmurthy Sravan; Namrata Heda; M Vijaya Kumar; Geetashree Mukherjee; Devaveena Dey; Annapoorni Rangarajan
Journal:  Breast Cancer Res       Date:  2014-08-06       Impact factor: 6.466

View more
  80 in total

Review 1.  Starvation Responses Throughout the Caenorhabditis elegans Life Cycle.

Authors:  L Ryan Baugh; Patrick J Hu
Journal:  Genetics       Date:  2020-12       Impact factor: 4.562

Review 2.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

3.  AMPKα2 Regulates Bladder Cancer Growth through SKP2-Mediated Degradation of p27.

Authors:  Stavros Kopsiaftis; Katie L Sullivan; Isha Garg; John A Taylor; Kevin P Claffey
Journal:  Mol Cancer Res       Date:  2016-09-16       Impact factor: 5.852

Review 4.  MicroRNAs as biomarkers in the diagnosis and treatment of chondrosarcoma.

Authors:  Feifei Pu; Fengxia Chen; Zengwu Shao
Journal:  Tumour Biol       Date:  2016-10-11

Review 5.  Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.

Authors:  Katrina E Allison; Brenda L Coomber; Byram W Bridle
Journal:  Immunology       Date:  2017-07-10       Impact factor: 7.397

6.  PTEN Deficiency and AMPK Activation Promote Nutrient Scavenging and Anabolism in Prostate Cancer Cells.

Authors:  Seong M Kim; Tricia T Nguyen; Archna Ravi; Peter Kubiniok; Brendan T Finicle; Vaishali Jayashankar; Leonel Malacrida; Jue Hou; Jane Robertson; Dong Gao; Jonathan Chernoff; Michelle A Digman; Eric O Potma; Bruce J Tromberg; Pierre Thibault; Aimee L Edinger
Journal:  Cancer Discov       Date:  2018-03-23       Impact factor: 39.397

Review 7.  Metabolic pathways in obesity-related breast cancer.

Authors:  Kristy A Brown
Journal:  Nat Rev Endocrinol       Date:  2021-04-29       Impact factor: 43.330

Review 8.  Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities.

Authors:  Giorgia Zadra; Massimo Loda
Journal:  Cold Spring Harb Perspect Med       Date:  2018-10-01       Impact factor: 6.915

Review 9.  Unraveling the actions of AMP-activated protein kinase in metabolic diseases: Systemic to molecular insights.

Authors:  Karen A Weikel; Neil B Ruderman; José M Cacicedo
Journal:  Metabolism       Date:  2016-01-14       Impact factor: 8.694

10.  Adenosine enhances cisplatin sensitivity in human ovarian cancer cells.

Authors:  Parichat Sureechatchaiyan; Alexandra Hamacher; Nicole Brockmann; Bjoern Stork; Matthias U Kassack
Journal:  Purinergic Signal       Date:  2018-08-04       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.